Belite Bio (BLTE) Research & Development (2022 - 2026)

Belite Bio's Research & Development history runs 5 years deep, the most recent figure standing at $15.7 million for Q1 2026.

• In Q1 2026, Research & Development rose 66.68% year-over-year to $15.7 million; the TTM figure through Mar 2026 stood at $36.0 billion (up 55.26% YoY), while the FY2025 annual figure was $45.4 million, up 51.56% from the prior year.
• Research & Development for Q1 2026 stood at $15.7 million, down from $14.6 billion in the prior quarter.
• The five-year high for Research & Development was $14.6 billion in Q4 2025, with the low at $4.9 million in Q4 2023.
• The 5-year median for Research & Development is $5.6 billion (2023), against an average of $5.0 billion.
• The sharpest annual moves came in 2024 and 2025: Research & Development jumped 149097.86% in 2024, then sank 99.86% in 2025.
• Belite Bio's Research & Development stood at $5.2 million in 2022, then slipped by 6.97% to $4.9 million in 2023, then surged by 149097.86% to $7.3 billion in 2024, then soared by 101.6% to $14.6 billion in 2025, then tumbled by 99.89% to $15.7 million in 2026.
• Business Quant data shows BLTE's Research & Development at $15.7 million in Q1 2026, $14.6 billion in Q4 2025, and $10.3 billion in Q3 2025.